Teratogenic medication: are women adequately informed about the risks in pregnancy?
dc.contributor.advisor | Henderson, B. D. | |
dc.contributor.advisor | Van Wyk, C. | |
dc.contributor.author | Conradie, Maureen | |
dc.date.accessioned | 2018-10-18T07:53:23Z | |
dc.date.available | 2018-10-18T07:53:23Z | |
dc.date.issued | 2017-09 | |
dc.description.abstract | Abstract not available | en_ZA |
dc.identifier.uri | http://hdl.handle.net/11660/9391 | |
dc.language.iso | en | en_ZA |
dc.publisher | University of the Free State | en_ZA |
dc.rights.holder | University of the Free State | en_ZA |
dc.subject | Pregnancy risks | en_ZA |
dc.subject | Teratogenic medication | en_ZA |
dc.subject | Congenital anomalies | en_ZA |
dc.subject | Birth defects | en_ZA |
dc.subject | Dissertation (M.Med. (Clinical Genetics))--University of the Free State, 2017 | en_ZA |
dc.title | Teratogenic medication: are women adequately informed about the risks in pregnancy? | en_ZA |
dc.type | Dissertation | en_ZA |